Dianthus Therapeutics, Inc. - DNTH

SEC FilingsOur DNTH Tweets

About Gravity Analytica

Recent News

  • 06.05.2025 - Jefferies Global Healthcare Conference
  • 06.05.2025 - Jefferies Global Healthcare Conference
  • 05.29.2025 - Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference
  • 05.29.2025 - Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference
  • 05.22.2025 - Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors
  • 05.22.2025 - Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors
  • 05.22.2025 - Simon Read, Ph.D.
  • 05.22.2025 - Simon Read, Ph.D.
  • 05.14.2025 - Bank of America 2025 Health Care Conference

Recent Filings

  • 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.22.2025 - 3 Initial statement of beneficial ownership of securities
  • 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.22.2025 - 8-K Current report
  • 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors